Biotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from Obamacare

Biotechnology stocks and sector-related exchange traded funds surged Wednesday as Vice President-elect Mike Pence stated that President-elect Donald Trump’s “first order of business” was to repeal the Affordable Care Act and smoothly transition to a “market-based” system. Leading the jump on Wednesday, the BioShares Biotechnology Clinical Trials Fund (NasdaqGM: BBC), which is comprised of up-and-coming…Click to read more at